Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Post by thebanker32on Jul 08, 2010 1:52pm
516 Views
Post# 17254278

Level 2

Level 2

Cours niveau 2 pour STEM CELL THERAPEUTICS CORP (SSS: TSX Venture)

  Cours acheteur

 

  Cours vendeur

  Cours

  Nombre de lots

  # d'ordres

 

  Cours

  Nombre de lots

  # d'ordres

 

0,05 $

1157

50

 

0,055 $

323

6

0,045 $

1100

20

 

0,06 $

894

20

0,04 $

1050

15

 

0,065 $

630

13

0,035 $

319

10

 

0,07 $

380

12

0,03 $

605

12

 

0,075 $

705

9

0,025 $

130

2

 

0,08 $

138

5

0,02 $

1119

8

 

0,085 $

54

3

0,015 $

320

7

 

0,09 $

128

3

0,01 $

733

8

 

0,095 $

57

2

0,005 $

50

1

 

0,10 $

3

1

Bullboard Posts